News & Events
-
June 28, 2018
Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference
Jane Larkindale, Executive Director of D-RSC, attended the Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference in Scottsdale, AZ on June 28 – July 1. She participated on a panel, Today’s Tomorrow: Looking at the Future and presented two posters: Accelerating drug development: data sharing and developing quantitative tools through the Duchenne Regulatory Science Consortium (D-RSC)... - June 24, 2018
-
June 6, 2018 - June 7, 2018
Third Annual CPP Member Meeting 2018
The third annual CPP Member Meeting (June 6-7, 2018 in London, UK) provided a face-to-face forum for industry, regulators, academic experts and advocacy organizations to collaborate towards the development of Parkinson’s disease therapies. This meeting provided a unique opportunity for stakeholders to celebrate the successes of the consortium to date and align on future options... -
June 1, 2018
Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop
Kluetz PG, Kanapuru B, Lemery S, Johnson LL, Fiero M, Arscott K, Barbachano Y, Basch E, Campbell M, Cappelleri JC, Cella D, Cleeland C, Coens C, Daniels S, Denlinger CS, Fairclough DL, Hillard JR, Minasian L, Mitchell SA, O’Connor D, Patel S, Rubin EH, Ryden A, Soltys K, Sridhara R, Thanarajasingam G, Velikova G, Coons SJ. Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop. Value in Health 2018;21:742-747.
-
June 1, 2018
Mycobacterial biomaterials and resources for researchers
Hazbón MH, Rigouts L, Schito M, Ezewudo M, Kudo T, Itoh T, et al. Mycobacterial biomaterials and resources for researchers. Pathog Dis. 2018 Jun 1;76(4).
